Prevalence assessment adjusted for laboratory test performance using an example of the COVID-19 serological tests

Assessment of the prevalence disease or condition should consider accuracy diagnostic tests. In context new coronavirus infection (COVID-19) pandemic, laboratory testing has been one most important components overall strategy for control and prevention this infection. Seroprevalence studies have used to assess monitor level population immunity virus.
 paper we provide detailed description methods calculate interpret tests as well their sensitivity, specificity, positive- negative prognostic values using seroprevalence COVID-19 an example better understanding methodological issues. The use in demonstrated. A sample syntax confidence intervals estimates bootstrap procedure with known absolute true positive results, false results R software is also provided. Presentation adjusted test performance indicators improves comparability findings obtained different serological tests.
 article intended undergraduate-, postgraduate-, doctoral students health sciences working assessment (seroprevalence) diseases conditions through population-based surveys.